CORBUS PHARMACEUTICALS

Corbus Pharmaceuticals Reports 3rd Quarter 2024 Financial Results and Provides a Corporate Update

07 Nov 2024 06:00:01 By Nasdaq GlobeNewswire

Corbus Pharmaceuticals Presents New CRB-913 Pre-Clinical Data At Obesity Week 2024

04 Nov 2024 06:00:00 By Nasdaq GlobeNewswire

Corbus Pharmaceuticals to Present at the Guggenheim Securities Healthcare Innovation Conference

29 Oct 2024 07:00:01 By Nasdaq GlobeNewswire

Corbus Announces Enrollment Completion of Dose Escalation Stage of Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC (CRB-701)

16 Oct 2024 07:00:00 By Nasdaq GlobeNewswire

Corbus Pharmaceuticals to Participate in the BMO Capital Markets’ Oncology Summit

26 Sep 2024 07:00:00 By Nasdaq GlobeNewswire

Corbus Pharmaceuticals to Present at the 2024 Cantor Global Health Conference

05 Sep 2024 07:00:00 By Nasdaq GlobeNewswire

Corbus Pharmaceuticals Strengthens Board of Directors with Appointment of Winston Kung

20 Aug 2024 07:00:00 By Nasdaq GlobeNewswire

Corbus Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides a Corporate Update

06 Aug 2024 07:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

31 Jul 2024 09:44:31 By NetDania Notify

Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences in August

30 Jul 2024 07:50:40 By Nasdaq GlobeNewswire

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

16 Jul 2024 08:55:39 By NetDania Notify

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

15 Jul 2024 09:01:36 By NetDania Notify

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

12 Jul 2024 09:50:10 By NetDania Notify

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

12 Jun 2024 08:45:05 By NetDania Notify

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

11 Jun 2024 15:10:04 By NetDania Notify

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

03 Jun 2024 09:16:45 By NetDania Notify

SYS6002 (CRB-701) A Next-Generation Nectin-4 Targeting Antibody Drug Conjugate Continues to Demonstrate Encouraging Safety and Efficacy Observed in Patients with Nectin-4 Positive Tumors in a Clinical Update Presented at ASCO 2024

01 Jun 2024 09:00:00 By Nasdaq GlobeNewswire

Corbus Pharmaceuticals to Present at the 45th Annual Goldman Sachs Global Healthcare Conference

30 May 2024 07:00:00 By Nasdaq GlobeNewswire

Updated Phase 1 Clinical Data for SYS-6002 (CRB-701) to be presented at 2024 ASCO Annual Meeting

23 May 2024 16:05:26 By Nasdaq GlobeNewswire

NetDania - New 12 months High: CORBUS PHARMACEUTICALS HOLDINGS INC. - COMMON STO

21 May 2024 09:10:19 By NetDania Notify